化合物VP3.15 dihydrobromide T5956

Product Introduction
Bioactivity


英文名: VP3.15 dihydrobromide

描述: VP3.15 dihydrobromide 是一种口服具有活力的、高效的、CNS 可渗透的PDE7-GSK3双重抑制剂，对 PDE7 和 GSK3 作用的IC50值分别为 1.59 μM 和 0.88 μM。它具有神经保护和神经修复作用，可用于研究多发性硬化症 (MS) 潜在的抗炎和促髓鞘再生联合。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 22.5 mg/mL (42.59 mM)


关键字: Glycogen synthase kinase-3 | VP3.15 dihydrobromide | inhibit | VP3.15 | Inhibitor | VP-3.15 dihydrobromide | Glycogen synthase kinase 3 | GSK-3 | VP3.15 Dihydrobromide | Phosphodiesterase (PDE)

相关产品: BIO-acetoxime | A-443654 | Aloisine B | GNF4877 | hAChE-IN-5 | Bakkenolide A | PF-04802367 | KY19382 | SB 415286 | CHIR-99021

相关库: Antioxidant Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Metabolism Disease Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Pancreatic Cancer Compound Library | NO PAINS Compound Library | Bioactive Compound Library

化合物VP3.15 dihydrobromide T5956信息由TargetMol中国为您提供，如您想了解更多关于化合物VP3.15 dihydrobromide T5956报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途